Table 7

 ACR 20, 50 and 70 response at 0–18 months for those who were randomised in phase II

Combination (n = 56)SASP alone (n = 55)MTX alone (n = 54)
ACR, American College of Rheumatology; MTX, methotrexate; SASP, sulfasalazine.
ACR 20 response483233
ACR 50 response25107
ACR 70 response1374